AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionSkopos Labs, Inc.
Latest Disclosed Ownership63,195 shares
Latest Disclosed Value $ 13,744,122
Skopos Labs, Inc. reports 38.57% increase in ownership of ABBV / AbbVie Inc.

On April 29, 2026 - Skopos Labs, Inc. filed a 13F-HR form disclosing ownership of 63,195 shares of AbbVie Inc. (US:ABBV) valued at $13,744,281 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 45,605 shares of AbbVie Inc.. This represents a change in shares of 38.57% during the quarter. The current value of the position is $14,359,800 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ABBVIE COM 00287Y109 63,195 17,590 38.57 13,744 30.56 0.4294
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 45,605 20,811 83.94 10,527 137.84 0.4855
2025-11-14 2025-09-30 13F/A-2 ABBVIE COM 00287Y109 24,794 -806 -3.15 4,426 -3.15 0.5978
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 32,372 6,772 7,495 0.5179
2025-08-14 2025-06-30 13F/A-1 ABBVIE COM 00287Y109 25,600 5,021 24.40 4,570 6.01 0.5999
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 20,579 0 4,312 0.9310
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 20,579 5,241 34.17 4,312 58.20 0.9310
2025-01-15 2024-12-31 13F ABBVIE COM 00287Y109 15,338 3,502 29.59 2,725 16.60 0.8122
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 11,836 1,779 17.69 2,337 28.62 0.7690
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 10,057 0 0.00 1,818 0.00 0.7820
2024-05-07 2024-03-31 13F ABBVIE COM 00287Y109 10,057 264 2.70 1,818 19.78 0.7820
2024-02-09 2023-12-31 13F ABBVIE COM 00287Y109 9,793 9,793 1,518 0.7235
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.